2. 您的位置
3. 首页
4. 会议论文
5. Efficacy and Safety of Adalimumab Biosimilar(ExemptiaTM)in Ankylosing Spondylitis

Efficacy and Safety of Adalimumab Biosimilar(ExemptiaTM)in Ankylosing Spondylitis

来源 :2016年第18届亚太风湿病协会联盟大会(APLAP) | 被引量 : 0次 | 上传用户：chengyo

【作 者】

：

S.Bandyopadhyay A.Ray R.Sarkar 

【机 构】

：

Apollo Gleneagles Hospital,Medicine,Kolkata,India

【出 处】

：

2016年第18届亚太风湿病协会联盟大会(APLAP)

【发表日期】

：

2016年3期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Serum level of the vascular endothelial growth factor is elevated in ankylosing spondylitis and oste

会议

The ratio of patients who were diagnosed with ankylosing spondylitis by sacroiliac joint MRI

会议

The safety of anti-TNF therapy in ankylosing spondylitis patients with occult hepatitis B viral infe

会议

EFFECT OF LONG TERM BIOLOGIC AGENT TREATMENT ON DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYL

会议

Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis

会议

Immunohistologic analysis of early sacroiliitis in patients with spondyloarthropathies

会议

Efficacy and safety of glucocorticosteroids combined with ursodeoxycholic acid for PBC:a metaanalysi

会议

Combination therapy of NSAIDs and DMARDs alleviate the inflammation in patients with SAPHO syndrome:

会议

Infliximab treatment efficacy in distal extremity swelling with pitting edema associated with Spondy

会议

Secukinumab improves patient-reported outcomes in active ankylosing spondylitis:2-year results from

会议